id: telemedicine_use_to_diabetes_control_hba1c_8
name: Telemedicine Use â†’ Glycemic Control (HbA1c)
from_node:
  node_id: telemedicine_use
  node_name: Telemedicine Use
to_node:
  node_id: diabetes_control_hba1c_8
  node_name: Glycemic Control (HbA1c)
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Telemedicine platforms enable remote monitoring and communication between
  patients with diabetes and healthcare providers'
- 'Step 2: Increased frequency of contact and real-time feedback facilitates more
  responsive medication adjustments and lifestyle coaching'
- 'Step 3: Enhanced patient engagement and self-efficacy support improved adherence
  to diabetes management protocols'
- 'Step 4: Regular monitoring and timely interventions lead to better glycemic control,
  though effects on HbA1c are inconsistent across studies'
evidence:
  quality_rating: B
  n_studies: 4
  primary_citation: 'Wenhang Zhang et al. 2020. Effect of Telemedicine on Quality
    of Care in Patients with Coexisting Hypertension and Diabetes: A Systematic Review
    and Meta-Analysis. Telemedicine journal and e-health.'
  supporting_citations: []
description: Telemedicine interventions for patients with diabetes (particularly those
  with comorbid hypertension) show potential to improve glycemic control through enhanced
  monitoring, patient engagement, and self-management support. However, evidence from
  this meta-analysis of 4 clinical trials indicates inconsistent effects on HbA1c
  outcomes specifically, while other quality of care indicators including patient
  experience showed improvement.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
moderators:
- name: comorbid hypertension
  direction: strengthens
  strength: moderate
  description: Patients with coexisting hypertension and diabetes may benefit more
    from telemedicine for comprehensive chronic disease management
- name: intervention duration
  direction: strengthens
  strength: weak
  description: Intervention durations ranged from 3-6 months; longer interventions
    may show more consistent effects on glycemic control
